Patent Assignment
Reel/Frame 024863/0425
Change of Name
Recorded: 2010-08-19
Pages: 3
Assignor
MDRNA, INC.
Executed: 2010-07-21
Assignee
MARINA BIOTECH, INC.
3830 MONTE VILLA PARKWAY, BOTHELL, WASHINGTON, 98021
Covered Property
(1)
Method of Treating an Inflammatory Disease by Double Stranded Ribonucleic Acid
Application:
11/576,139 →
Publication:
US 2010/0113332
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 4, 2007
From: CHEN, LISHAN; CUI, KUNYUAN; HOUSTON, MICHAEL E., JR.; CHEN, YUCHING
To: NASTECH PHARMACEUTICAL COMPANY INC.
Reel/Frame 019113/0278 →
Security Agreement
Dec 29, 2009
From: MDRNA, INC.; MDRNA RESEARCH, INC.; NASTECH PHARMACEUTICAL COMPANY, INC.
To: EOS HOLDINGS LLC, AS AGENT
Reel/Frame 023708/0389 →
Release of Security Interest
Feb 23, 2010
From: EOS HOLDINGS LLC, AS AGENT
To: MDRNA, INC.; MDRNA RESEARCH, INC.; NASTECH PHARMACEUTICAL COMPANY, INC.
Reel/Frame 023973/0286 →
Change of Name
Feb 25, 2010
From: NASTECH PHARMACEUTICAL COMPANY, INC.
To: MDRNA, INC.
Reel/Frame 023993/0447 →
Security Agreement (Patents)
Apr 28, 2010
From: MDRNA, INC. FKA NASTECH PHARMACEUTICAL COMPANY INC.
To: CEQUENT PHARMACEUTICALS, INC.
Reel/Frame 024300/0825 →
Release of Security Interest
Jul 30, 2010
From: CEQUENT PHARMACEUTICALS, INC.
To: MARINA BIOTECH, INC. (F/K/A MDRNA, INC.)
Reel/Frame 024767/0466 →
Security Agreement
Feb 15, 2012
From: MARINA BIOTECH, INC; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
To: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
Reel/Frame 027712/0200 →
Release of Security Interest
Apr 14, 2014
From: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
To: MARINA BIOTECH, INC.; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
Reel/Frame 032685/0158 →